ATE437361T1 - Hairless-protein-interagierender partner komplex und methoden zur verschönerung und/oder verbesserung von säugetierhaut - Google Patents

Hairless-protein-interagierender partner komplex und methoden zur verschönerung und/oder verbesserung von säugetierhaut

Info

Publication number
ATE437361T1
ATE437361T1 AT04810571T AT04810571T ATE437361T1 AT E437361 T1 ATE437361 T1 AT E437361T1 AT 04810571 T AT04810571 T AT 04810571T AT 04810571 T AT04810571 T AT 04810571T AT E437361 T1 ATE437361 T1 AT E437361T1
Authority
AT
Austria
Prior art keywords
improvement
methods
beauty
hairless protein
interacting partner
Prior art date
Application number
AT04810571T
Other languages
English (en)
Inventor
Kotikanyadanam Sreekrishna
Robert Leboeuf
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE437361T1 publication Critical patent/ATE437361T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04810571T 2003-11-13 2004-11-09 Hairless-protein-interagierender partner komplex und methoden zur verschönerung und/oder verbesserung von säugetierhaut ATE437361T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/712,629 US20050106141A1 (en) 2003-11-13 2003-11-13 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin
PCT/US2004/037263 WO2005050201A2 (en) 2003-11-13 2004-11-09 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin

Publications (1)

Publication Number Publication Date
ATE437361T1 true ATE437361T1 (de) 2009-08-15

Family

ID=34573585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04810571T ATE437361T1 (de) 2003-11-13 2004-11-09 Hairless-protein-interagierender partner komplex und methoden zur verschönerung und/oder verbesserung von säugetierhaut

Country Status (8)

Country Link
US (1) US20050106141A1 (de)
EP (2) EP1685402B1 (de)
JP (1) JP4557983B2 (de)
CN (1) CN1882837A (de)
AT (1) ATE437361T1 (de)
CA (1) CA2545251A1 (de)
DE (1) DE602004022189D1 (de)
WO (1) WO2005050201A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106906180A (zh) 2016-12-28 2017-06-30 里程 一种具有生物活化作用的复合添加剂及其制备方法和用途
CN112642002B (zh) * 2020-08-25 2022-04-15 中国医学科学院北京协和医院 可用于激活和修复皮肤干细胞功能的生物材料的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62169711A (ja) * 1986-01-22 1987-07-25 Shiseido Co Ltd 皮膚化粧料
JPS63145211A (ja) * 1986-12-05 1988-06-17 Piasuaraizu Kk ビタミン配合化粧料
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US5986055A (en) * 1997-11-13 1999-11-16 Curagen Corporation CDK2 interactions
AU2572499A (en) * 1998-01-29 1999-08-16 Trustees Of Columbia University In The City Of New York, The Human hairless gene, protein and uses thereof
US6348348B1 (en) * 1998-04-07 2002-02-19 The Carnegie Institution Of Washington Human hairless gene and protein
JP2002326922A (ja) * 2001-03-01 2002-11-15 Kose Corp 皮膚外用剤
EP1262168A1 (de) * 2001-03-23 2002-12-04 L'oreal Zusammensetzung zur Bekämpfung des Hautalterns, die Fasern enthält
US20040086945A1 (en) * 2002-06-03 2004-05-06 The Procter & Gamble Company Hairless protein-interacting partner complexes and methods thereto

Also Published As

Publication number Publication date
JP4557983B2 (ja) 2010-10-06
WO2005050201A2 (en) 2005-06-02
EP1685402A2 (de) 2006-08-02
WO2005050201A3 (en) 2006-03-23
EP2208997A3 (de) 2010-09-01
DE602004022189D1 (de) 2009-09-03
JP2007516236A (ja) 2007-06-21
EP2208997A2 (de) 2010-07-21
US20050106141A1 (en) 2005-05-19
EP1685402B1 (de) 2009-07-22
CN1882837A (zh) 2006-12-20
CA2545251A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
DE60029572D1 (de) Isolierung und analyse von proteinen
ATE494883T1 (de) Zusammensetzung zur färbung von keratinfaser, die spezielle aminosilikonen enthält
DE69911312D1 (de) Eisenoxidnanopigmente enthaltende Zusammensetzungen für die künstliche Bräunung der Haut und andere Verwendungen
ATE442064T1 (de) Make-up-kit und -verfahren
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
DE60237221D1 (de) Kosmetische und dermopharmazeutische zusammensetzungen für akneanfällige haut
ATE516305T1 (de) Il-15-bindungsstelle für il-15-ralpha und spezifische il-15-mutanten mit wirkung als agonisten/antagonisten
CY1108580T1 (el) Αυτοανοσες παθησεις και ελλειμματα nadph οξειδασης
ATE465257T1 (de) Agonisten für den rezeptor des hepatozyten- wachstumsfaktors und deren anwendungen
DE602004022124D1 (de) Verfahren und Anordung zur Begutachtung der Qualität von maschineller Übersetzung
RS51903B (sr) Formulacija aripiprazol kompleksa i postupak
ATE443260T1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
ATE295899T1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
DE602004032018D1 (de) Kosmetische zusammensetzungen und verfahren zu ihrscheinungsbilds der haut
WO2004066958A3 (en) Caspase-9:bir3 domain of xiap complexes and methods of use
DE50003729D1 (de) Verwendung von emulsionen als imprägnier- und avivagemittel
ATE453624T1 (de) Kristallform von lercanipidin-hydrochlorid zur verwendung als antihypertensives mittel
DE602005024569D1 (de) Kosmetische zusammensetzungen mit fluoreszenten farbstoffen für natürliche hautfarbe
BR0105795A (pt) Triagem de alta produção de bibliotecas de dna expressadas em fungos filamentosos
ATE486931T1 (de) Hybridpolymerase-verfahren und -zusammensetzungen
ATE437361T1 (de) Hairless-protein-interagierender partner komplex und methoden zur verschönerung und/oder verbesserung von säugetierhaut
FR2841550B1 (fr) Nouvelles molecules derivees de la tyramine, leur mode de preparation, et leur utilisation seules ou associees dans des compositions cosmetiques ou dermopharmceutiques
DE60230133D1 (de) Toluolsulfonamid enthaltende antitumorale zusammensetzung und anwendungsverfahren dafür
DE60226324D1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
DE50307180D1 (de) Verwendung von perfluoralkylhaltigen metallkomplexen als kontrastmittel im mr-imaging zur darstellung von intravasalen thromben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties